Regulatory T Cells pp 157-172

Part of the Methods in Molecular Biology book series (MIMB, volume 707)

In Vivo Depletion of FoxP3+ Tregs Using the DEREG Mouse Model

  • Katharina Lahl
  • Tim Sparwasser


In recent years, researchers have increasingly focused on the modulation of regulatory T cell (Treg) function to interfere with the outcome of virtually every type of immune response. For a long time, specific in vivo targeting of Tregs was precluded due to the lack of appropriate markers. Only after the discovery of Foxp3 as a Treg-specific transcription factor, was the development of Treg-specific mouse models feasible. We generated DEREG mice (DEpletion of REGulatory T cells), a BAC (bacterial artificial chromosome) transgenic mouse line, which allows direct in vivo analysis and depletion of this exceedingly important cell type. Our DEREG mice carry a DTR-eGFP transgene under the control of an additional Foxp3 promoter, thereby allowing specific depletion of Treg by application of diphtheria toxin at any desired point of time during an ongoing immune response. This chapter will elaborate the advantages and disadvantages of employing different genetic approaches and discuss further parameters used in the studies focusing on employment of diphtheria toxin and its degree of general toxicity in mice. Additionally, we will address the question: to which extent DEREG mice are suitable for studying the effect of long-term Treg depletion during specific immune responses.

Key words

DEREG DT mediated Treg depletion Long-term depletion Depletion efficacy 


  1. 1.
    Sakaguchi, S. et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (3), 1151–1164PubMedGoogle Scholar
  2. 2.
    Sakaguchi, S. (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22, 531–562PubMedCrossRefGoogle Scholar
  3. 3.
    Belkaid, Y. and Rouse, B.T. (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6 (4), 353–360PubMedCrossRefGoogle Scholar
  4. 4.
    Fontenot, J.D. et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (3), 329–341PubMedCrossRefGoogle Scholar
  5. 5.
    Wan, Y.Y. and Flavell, R.A. (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 102 (14), 5126–5131PubMedCrossRefGoogle Scholar
  6. 6.
    Stephens, L.A. and Mason, D. (2000) CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25− subpopulations. J Immunol 165 (6), 3105–3110PubMedGoogle Scholar
  7. 7.
    Lehmann, J. et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25− regulatory T cells. Proc Natl Acad Sci U S A 99 (20), 13031–13036PubMedCrossRefGoogle Scholar
  8. 8.
    Kohm, A.P. et al. (2006) Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176 (6), 3301–3305PubMedGoogle Scholar
  9. 9.
    Couper, K.N. et al. (2009) Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection. J Immunol 182 (7), 3985–3994PubMedCrossRefGoogle Scholar
  10. 10.
    Couper, K.N. et al. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol 178 (7), 4136–4146PubMedGoogle Scholar
  11. 11.
    Saito, M. et al. (2001) Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 19 (8), 746–750PubMedCrossRefGoogle Scholar
  12. 12.
    Naglich, J.G. et al. (1992) Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69 (6), 1051–1061PubMedCrossRefGoogle Scholar
  13. 13.
    Mitamura, T. et al. (1997) Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis. J Biol Chem 272 (43), 27084–27090PubMedCrossRefGoogle Scholar
  14. 14.
    Jung, S. et al. (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17 (2), 211–220PubMedCrossRefGoogle Scholar
  15. 15.
    Fontenot, J.D. et al. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (4), 330–336PubMedCrossRefGoogle Scholar
  16. 16.
    Hori, S. et al. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (5609), 1057–1061PubMedCrossRefGoogle Scholar
  17. 17.
    Yang, X.W. et al. (1997) Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol 15 (9), 859–865PubMedCrossRefGoogle Scholar
  18. 18.
    Heintz, N. (2001) BAC to the future: the use of bac transgenic mice for neuroscience research. Nat Rev Neurosci 2 (12), 861–870PubMedCrossRefGoogle Scholar
  19. 19.
    Sparwasser, T. and Eberl, G. (2007) BAC to immunology – bacterial artificial chromosome-mediated transgenesis for targeting of immune cells. Immunology 121 (3), 308–313PubMedCrossRefGoogle Scholar
  20. 20.
    McKnight, R.A. et al. (1992) Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A 89 (15), 6943–6947PubMedCrossRefGoogle Scholar
  21. 21.
    Brunkow, M.E. et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (1), 68–73PubMedCrossRefGoogle Scholar
  22. 22.
    Sparwasser, T. et al. (2004) General method for the modification of different BAC types and the rapid generation of BAC transgenic mice. Genesis 38 (1), 39–50PubMedCrossRefGoogle Scholar
  23. 23.
    Duffield, J.S. et al. (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115 (1), 56–65PubMedGoogle Scholar
  24. 24.
    Cailhier, J.F. et al. (2005) Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J Immunol 174 (4), 2336–2342PubMedGoogle Scholar
  25. 25.
    Walzer, T. et al. (2007) Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A 104 (9), 3384–3389PubMedCrossRefGoogle Scholar
  26. 26.
    Bennett, C.L. et al. (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169 (4), 569–576PubMedCrossRefGoogle Scholar
  27. 27.
    Kissenpfennig, A. et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (5), 643–654PubMedCrossRefGoogle Scholar
  28. 28.
    Buch, T. et al. (2005) A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2 (6), 419–426PubMedCrossRefGoogle Scholar
  29. 29.
    Lahl, K. et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204 (1), 57–63PubMedCrossRefGoogle Scholar
  30. 30.
    Kim, J.M. et al. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8 (2), 191–197PubMedCrossRefGoogle Scholar
  31. 31.
    Feuerer, M. et al. (2009) How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31 (4), 654–664PubMedCrossRefGoogle Scholar
  32. 32.
    McHugh, R.S. and Shevach, E.M. (2002) Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 168 (12), 5979–5983PubMedGoogle Scholar
  33. 33.
    Lahl, K. et al. (2009) Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J Immunol 183 (9), 5662–5672PubMedCrossRefGoogle Scholar
  34. 34.
    Heit, A. et al. (2008) Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity. Eur J Immunol 38 (6), 1585–1597PubMedCrossRefGoogle Scholar
  35. 35.
    Mariathasan, S. et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430 (6996), 213–218PubMedCrossRefGoogle Scholar
  36. 36.
    Luo, Y. and Dorf, M.E. (2001) Delayed-type hypersensitivity. Curr Protoc Immunol Chapter 4, Unit 4.5Google Scholar
  37. 37.
    Thornton, A.M. and Shevach, E.M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188 (2), 287–296PubMedCrossRefGoogle Scholar
  38. 38.
    Komatsu, N. and Hori, S. (2007) Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras. Proc Natl Acad Sci U S A 104 (21), 8959–8964PubMedCrossRefGoogle Scholar
  39. 39.
    Kim, J. et al. (2009) Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 183(12), 7631–7763PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Katharina Lahl
    • 1
  • Tim Sparwasser
    • 2
  1. 1.School of MedicineStanford UniversityStanfordUSA
  2. 2.Institute of Infection Immunology, TWINCORECenter for Experimental and Clinical Infection ResearchHannoverGermany

Personalised recommendations